Friday, October 06, 2017 10:15 PM ET
Significant Insider Sales Reported in Shares of CytomX Therapeutics (CTMX) Extending the Trend of Last Quarter
There was a substantial level of insider selling reported today in filings with the SEC for CytomX Therapeutics. Two insiders — Frederick W Gluck, Director, and Dr William Michael Kavanaugh, Officer — disposed of 58,368 shares in the company for approximately $1,419,957. There have been 3 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the disposition of 57,277 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 115,645 shares and have averaged 23,129 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at CytomX Therapeutics is greater than its 264-company peer group average. The Bio Therapeutic Drugs peer group saw 319 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by CytomX Therapeutics insiders is lower than its peers. Within the peer group there were 9,991,608 shares purchased and 20,879,887 shares sold with company insiders having sold 34,133 shares on average over this time period.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to evaluate and write this story.
Today’s Insider Activity
* Frederick W Gluck, Director, sold 10,000 shares
* Dr William Michael Kavanaugh, Officer, sold 48,368 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.